๐Ÿ”ฌDeep Research

BIOA โ€” BioAge Labs Inc ยท catalysts, narrative & risks

ยท19 sourcesBIOA forecast โ†’

BioAge Labs (BIOA) โ€” Point-in-Time Snapshot

BioAge Labs, Inc. trades on the NASDAQ under ticker BIOA and is a clinical-stage biopharmaceutical company developing therapeutic candidates for cardiometabolic diseases by targeting the biology of human aging. Its lead candidate, BGE-102, is an oral, brain-penetrant small-molecule NLRP3 inhibitor [2][7][8][14].


AI-assisted research from the K3vl4r desk โ€” not personalized investment advice. More research โ†’